Phase I study in healthy male and female volunteers. Intended indication: mood disorders research hub

A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy Volunteers

This study is testing a new medicine, PT00114, for mood disorders. It's the very first time humans are taking it. Researchers want to see if it's safe, how well people tolerate it, and what it does in the body. Healthy volunteers are needed.